Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ONM-501 by OncoNano Medicine for Lymphoma: Likelihood of Approval
ONM-501 is under clinical development by OncoNano Medicine and currently in Phase I for Lymphoma. According to GlobalData, Phase I...
ONM-501 by OncoNano Medicine for Solid Tumor: Likelihood of Approval
ONM-501 is under clinical development by OncoNano Medicine and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
ONM-501 by OncoNano Medicine for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
ONM-501 is under clinical development by OncoNano Medicine and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...